Skip to content

Clinical trials

Neoplasm Metastasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: China Clear all

360 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20064
20076
20086
20092
20107
201110
20127
20135
20143
201512
201612
201713
201815
201920
202021
202141
202233
202329
202433
202537
202642

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting114
Unknown status104
Completed70
Active, not recruiting33
Not yet recruiting22
Terminated12
Withdrawn3
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University24
AstraZeneca15
Sun Yat-sen University13
Eli Lilly and Company12
Chinese PLA General Hospital10
Novartis Pharmaceuticals8
Peking University Cancer Hospital & Institute7
Pfizer7
Beijing Biotech6
Chongqing Precision Biotech Co., Ltd6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis360
Breast Neoplasms64
Neoplasms40
Recurrence40
Colorectal Neoplasms37
Carcinoma, Non-Small-Cell Lung32
Stomach Neoplasms24
Ovarian Neoplasms20
Pancreatic Neoplasms19
Liver Neoplasms17

Trials

Showing 26 to 50 of 360. Each trial links to its page on Pharma Observatory.

260 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.